Skip to main content
CTKB logo
CTKB
(NASDAQ)
Cytek Biosciences, Inc.
$4.28-- (--)
Loading... - Market loading

Cytek Biosciences (CTKB) Stock Price & Financial Analysis

Cytek Biosciences Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.08 - $4.39
52-Week High$6.18
52-Week Low$3.09
Open$4.10
Volume1.49M
Average Volume (3M)1.87M
Market Cap550.86M
Shares Outstanding128.70M
Price to Sales (P/S)2.70
Price to Book (P/B)1.68
EV/EBITDA-23.55
Revenue (TTM)204.17M
Net Income (TTM)-74.00M
Free Cash Flow (TTM)-12.70M
EPS (TTM)$-0.58
Profit Margin-36.25%
Operating Margin-21.49%
Return on Equity (ROE)-22.59%
Debt to Equity0.11
50-Day MA$4.21
200-Day MA$4.48
52-Week Change32.51%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Cytek Biosciences

What is the current stock price for CTKB?

As of the latest trading session, CTKB stock trades at $4.28. The 52-week range is $3.09–$6.18, with a day range of $4.08–$4.39.

What is the P/E ratio for CTKB?

The P/E ratio (Price-to-Earnings) for CTKB is shown in the Key Statistics section. This valuation metric helps compare Cytek Biosciences, Inc. to industry peers.

Does CTKB pay dividends?

Cytek Biosciences does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CTKB?

Analyst ratings and recommendations for CTKB are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of CTKB?

Cytek Biosciences's market capitalization is $550.9M, classifying it as a small-cap company. Cytek Biosciences operates in the Healthcare sector within the Medical Devices industry.